These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18034251)

  • 41. Rheumatoid Arthritis: A Brief Overview of the Treatment.
    Bullock J; Rizvi SAA; Saleh AM; Ahmed SS; Do DP; Ansari RA; Ahmed J
    Med Princ Pract; 2018; 27(6):501-507. PubMed ID: 30173215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newly diagnosed rheumatoid arthritis.
    Weisman MH
    Ann Rheum Dis; 2002 Apr; 61(4):287-9. PubMed ID: 11874827
    [No Abstract]   [Full Text] [Related]  

  • 43. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
    Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
    J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [How does one manage patients with rheumatoid arthritis and positive serology to hepatitis B, hepatitis C, human immunodeficiency virus?].
    Cabrera Villalba SR; Victoria Hernández Miguel M; Sanmartí Sala R
    Reumatol Clin; 2011; 7(3):203-7. PubMed ID: 21794814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Counterintuitive Pulmonary Nodules in Rheumatoid Arthritis.
    Zamora FD; Podgaetz E; Dincer HE
    Arch Bronconeumol; 2016 Jun; 52(6):334-5. PubMed ID: 26818558
    [No Abstract]   [Full Text] [Related]  

  • 48. [Modern therapy of rheumatoid arthritis. Joint destruction can be delayed].
    Neumaier J
    MMW Fortschr Med; 2008 Apr; 150(14):14. PubMed ID: 18488571
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.
    Le Loët X; Berthelot JM; Cantagrel A; Combe B; De Bandt M; Fautrel B; Flipo RM; Lioté F; Maillefert JF; Meyer O; Saraux A; Wendling D; Guillemin F
    Ann Rheum Dis; 2006 Jan; 65(1):45-50. PubMed ID: 15994280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rheumatoid arthritis referrals and rheumatologist scarcity: a prioritization tool.
    Cummins LL; Vangaveti V; Roberts LJ
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):326-31. PubMed ID: 25156328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice.
    Irvine S; Munro R; Porter D
    Ann Rheum Dis; 1999 Aug; 58(8):510-3. PubMed ID: 10419871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of drug use in rheumatoid arthritis.
    Bérard A; Solomon DH; Avorn J
    J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
    Meyer O; de Bandt M; Berthelot JM; Cantagrel A; Combe B; Fautrel B; Flipo RM; Lioté F; Maillefert JF; Saraux A; Wendling D; Guillemin F; Le Loët X;
    Joint Bone Spine; 2007 Jan; 74(1):73-8. PubMed ID: 17194614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T; Sumida T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract]   [Full Text] [Related]  

  • 55. Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
    Kuijper TM; Lamers-Karnebeek FB; Jacobs JW; Hazes JM; Luime JJ
    J Rheumatol; 2015 Nov; 42(11):2012-22. PubMed ID: 26428204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
    Barber CEH; Marshall DA; Szefer E; Barnabe C; Shiff NJ; Bykerk V; Homik J; Thorne JC; Ahluwalia V; Benseler S; Mosher D; Twilt M; Lacaille D
    Arthritis Care Res (Hoboken); 2021 May; 73(5):640-648. PubMed ID: 32144843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 58. The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.
    Nikiphorou E; Galloway J; van Riel P; Yazici Y; Haugeberg G; Ostor A; Gogus F; Kauppi M; Sokka T;
    Clin Exp Rheumatol; 2017; 35(3):477-483. PubMed ID: 28134086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic corticosteroids in rheumatoid arthritis: to use or not to use?].
    Amano K
    Nihon Rinsho; 2002 Dec; 60(12):2364-9. PubMed ID: 12510363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.